市场调查报告书
商品编码
1467852
2024-2032 年按交付模式、组件、开发阶段、最终用户和地区分類的电子资料收集系统市场报告Electronic Data Capture Systems Market Report by Delivery Mode, Component, Development Phase, End User, and Region 2024-2032 |
IMARC Group年全球电子资料采集(EDC)系统市场规模达13亿美元。临床试验的快速数位化、云端系统的日益普及以及行动 EDC 的引入是推动市场发展的一些关键因素。
电子资料撷取(EDC)系统是指设计用于以电子格式收集和管理临床试验资料的软体工具。它们捕捉各种各样的资料,包括患者人口统计、病史、不良事件、实验室结果、临床结果评估、电子知情同意书 (eConsent) 和研究中心资讯。 EDC 系统被监管机构、临床试验申办者、合约研究组织 (CRO)、试验参与者和资料管理者广泛使用。它们有助于简化资料收集、提高资料品质、最大限度地减少人为错误、保护敏感资讯并降低资料遗失和重复的风险。 EDC系统还提高临床试验的效率,提供即时监测能力,辅助决策,并确保资料的准确性、可靠性和一致性。
全球临床试验的快速数位化是推动市场成长的主要因素之一。 EDC系统广泛用于自动化各种临床试验操作,例如资料收集、储存、监控和分析,从而加速流程、提供透明度、防止错误并提高整体效率。除此之外,由于糖尿病、高血压、阿兹海默症、多发性硬化症和心血管疾病(CVD)等慢性病的盛行率不断增加,对新疗法和疗法的需求不断增长,也是另一个生长诱导因素。此外,基于云端的系统的日益普及,具有成本效益、用户友好、可扩展、高度安全,并提供即时资料访问,正在为市场增长提供动力。此外,行动 EDC 的引入,利用智慧型手机或平板电脑作为一种方便且经济高效的方式来收集患者资料,从而提高参与度、提高合规性并降低错误风险,有利于市场成长。除此之外,机器学习 (ML) 和人工智慧 (AI) 的整合可改善资料分析、加快决策速度并识别模式、趋势和异常,这对市场成长产生了积极影响。此外,关于临床试验资料的安全性和完整性的严格政府法规的实施正在促进对先进资料管理和报告系统的需求,例如 EDC,这有助于确保更好地遵守当局的规定。其他因素,包括对个人化药物的需求不断增长、广泛的研发 (R&D) 活动以及对以患者为中心的临床试验的日益关注,预计将推动市场成长。
The global electronic data capture (EDC) systems market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2032, exhibiting a growth rate (CAGR) of 10.21% during 2024-2032. The rapid digitalization of clinical trials, the rising adoption of the cloud-based system, and the introduction of mobile-EDC represent some of the key factors driving the market.
Electronic data capture (EDC) systems refer to software tools designed to collect and manage clinical trial data in electronic format. They capture a wide variety of data, including patient demographics, medical history, adverse events, laboratory results, clinical outcome assessments, electronic informed consent (eConsent), and study site information. EDC systems are widely used by regulatory agencies, clinical trial sponsors, contract research organizations (CROs), trial participants, and data managers. They help streamline data collection, improve data quality, minimize human errors, protect sensitive information, and reduce the risk of data loss and duplications. EDC systems also enhance the efficiency of the clinical trial, provide real-time monitoring capabilities, assist in decision-making, and ensure data accuracy, reliability, and consistency.
The rapid digitalization of clinical trials across the globe is one of the primary factors propelling the market growth. EDC systems are widely used to automate various clinical trial operations, such as data collection, storage, monitoring, and analysis, which, in turn, accelerate the process, provide transparency, prevent errors, and improve overall efficiency. In addition to this, the growing demand for new treatments and therapeutics due to the increasing prevalence of chronic diseases, such as diabetes, hypertension, Alzheimer's disease, multiple sclerosis, and cardiovascular diseases (CVDs), are acting as another growth-inducing factor. Furthermore, the rising adoption of the cloud-based system, which is cost-effective, user-friendly, scalable, highly secure, and offers real-time access to data, is providing an impetus to the market growth. Additionally, the introduction of mobile-EDC, which utilize smartphones or tablets as a convenient and cost-effective way to collect patients' data, thus improving engagement, increasing compliance, and reducing the risk of errors, is favoring the market growth. Apart from this, the integration of machine learning (ML) and artificial intelligence (AI) to improve data analysis, enable faster decision-making, and identify patterns, trends, and anomalies is positively influencing the market growth. Moreover, the implementation of stringent government regulations regarding the safety and integrity of clinical trial data is facilitating the demand for advanced data management and reporting systems, such as EDC, which aids in ensuring greater compliance with the authorities. Other factors, including increasing demand for personalized medicines, extensive research and development (R&D) activities, and the growing focus on patient-centric clinical trials, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global electronic data capture (EDC) systems market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on delivery mode, component, development phase, and end user.
On-premise
Web & Cloud-based
The report has provided a detailed breakup and analysis of the electronic data capture (EDC) systems market based on the delivery mode. This includes on-premise and web & cloud-based. According to the report, web & cloud-based represented the largest segment.
Software
Services
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the component has also been provided in the report. This includes software and services. According to the report, services accounted for the largest market share.
Phase I
Phase II
Phase III
Phase IV
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the development phase has also been provided in the report. This includes phase I, phase II, phase III, and phase IV. According to the report, phase III accounted for the largest market share.
Hospitals/Healthcare Providers
CROs
Pharmaceutical and Biotechnology Firms
Medical Device Firms
Others
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the end user has also been provided in the report. This includes hospitals/healthcare providers, CROs, pharmaceutical and biotechnology firms, medical device firms, and others. According to the report, CROs accounted for the largest market share.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for electronic data capture (EDC) systems. Some of the factors driving the North America electronic data capture (EDC) systems market included the rising prevalence of chronic diseases, increasing government initiatives, and rapid technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global electronic data capture (EDC) systems market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Anju Software Inc., Calyx, Clario, Datatrak Int, Medidata Solutions Inc., OpenClinica, LLC, Oracle Corporation, Veeva Systems, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.